Author
Listed:
- Ysobel R. Baker
(University of Oxford, Chemistry Research Laboratory)
- Cameron Thorpe
(University of Oxford, Chemistry Research Laboratory)
- Jinfeng Chen
(University of Oxford, Chemistry Research Laboratory)
- Laura M. Poller
(University of Oxford, Chemistry Research Laboratory)
- Lina Cox
(University of Oxford, Chemistry Research Laboratory)
- Pawan Kumar
(University of Oxford, Chemistry Research Laboratory)
- Wooi F. Lim
(University of Oxford)
- Lillian Lie
(University of Oxford, Chemistry Research Laboratory)
- Graham McClorey
(University of Oxford)
- Sven Epple
(University of Oxford, Chemistry Research Laboratory)
- Daniel Singleton
(University of Southampton)
- Michael A. McDonough
(University of Oxford, Chemistry Research Laboratory)
- Jack S. Hardwick
(University of Oxford, Chemistry Research Laboratory)
- Kirsten E. Christensen
(University of Oxford, Chemistry Research Laboratory)
- Matthew J. A. Wood
(University of Oxford)
- James P. Hall
(University of Reading)
- Afaf H. El-Sagheer
(University of Oxford, Chemistry Research Laboratory
Suez University, Faculty of Petroleum and Mining Engineering)
- Tom Brown
(University of Oxford, Chemistry Research Laboratory)
Abstract
Oligonucleotides that target mRNA have great promise as therapeutic agents for life-threatening conditions but suffer from poor bioavailability, hence high cost. As currently untreatable diseases come within the reach of oligonucleotide therapies, new analogues are urgently needed to address this. With this in mind we describe reduced-charge oligonucleotides containing artificial LNA-amide linkages with improved gymnotic cell uptake, RNA affinity, stability and potency. To construct such oligonucleotides, five LNA-amide monomers (A, T, C, 5mC and G), where the 3′-OH is replaced by an ethanoic acid group, are synthesised in good yield and used in solid-phase oligonucleotide synthesis to form amide linkages with high efficiency. The artificial backbone causes minimal structural deviation to the DNA:RNA duplex. These studies indicate that splice-switching oligonucleotides containing LNA-amide linkages and phosphorothioates display improved activity relative to oligonucleotides lacking amides, highlighting the therapeutic potential of this technology.
Suggested Citation
Ysobel R. Baker & Cameron Thorpe & Jinfeng Chen & Laura M. Poller & Lina Cox & Pawan Kumar & Wooi F. Lim & Lillian Lie & Graham McClorey & Sven Epple & Daniel Singleton & Michael A. McDonough & Jack S, 2022.
"An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides,"
Nature Communications, Nature, vol. 13(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31636-2
DOI: 10.1038/s41467-022-31636-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31636-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.